Verastem (VSTM) Capital Expenditures Growth (1y) (2012 - 2021)
Verastem (VSTM) Capital Expenditures Growth (1y) (2012 - 2021) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Capex Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
- |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
227.76% |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Verastem |
407.42 Mn |
225.74 Mn |
15.90 Mn |
- |
| Date | Value |
|---|
| Mar 31, 2021 |
1,407.69% |
| Dec 31, 2015 |
100.42% |
| Sep 30, 2015 |
-99.45% |
| Mar 31, 2015 |
1,860.00% |
| Dec 31, 2014 |
-8,430.00% |
| Sep 30, 2014 |
28,900.00% |
| Dec 31, 2013 |
281.82% |
| Sep 30, 2013 |
-96.75% |
| Dec 31, 2012 |
-135.48% |
| Sep 30, 2012 |
-58.27% |
